Cite
HARVARD Citation
Verstovsek, S. et al. (2017). A phase 2 study of simtuzumab in patients with primary, post‐polycythaemia vera or post‐essential thrombocythaemia myelofibrosis. British journal of haematology. pp. 939-949. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Verstovsek, S. et al. (2017). A phase 2 study of simtuzumab in patients with primary, post‐polycythaemia vera or post‐essential thrombocythaemia myelofibrosis. British journal of haematology. pp. 939-949. [Online].